Clinical Trial

Topical Treatment for Atopic Dermatitis

Recruiting
View on ClinicalTrials.gov →
Summary
Medication adherence is a poorly studied phenomenon that challenges both patients and physicians. 50% of individuals with chronic disease are not adherent to their medication regimen. Within the United States, non-adherence to medical treatment leads to approximately $100 billion in hospital admission costs. While the issue of adherence is not limited to any particular field of medicine, non-adherence occurs in approximately one-third to one-half of dermatological patients. Non-adherence is of importance as it is a significant cause of treatment failure, resulting in worse quality of life, worse health outcomes, and increased insurance costs.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07 -> 2027-01 2026-08-05
minor Completion pushed: 2027-07 -> 2027-11 2026-08-05
Trial Details
NCT Number NCT06244212
Lead Sponsor Wake Forest University Health Sciences
Conditions Atopic Dermatitis
Enrollment 30 participants
Start Date 2024-09-19
Primary Completion 2027-01 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-04